BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Nutra Pharma Corp. 

3473 High Ridge Road

Boynton Beach  Florida  33426  U.S.A.
Phone: 954-509-0911 Fax: 877-895-5647


View Clinical Trials from BioPharm Insight

Nutra Pharma Corporation is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena. By bringing a solid business foundation to the Company's Biotech holdings, Nutra Pharma has the ability to accelerate business plans, streamline costs and bring products to the market or licensure in a time-effective manner.

Nutra Pharma currently has three holdings:

  • The minority-owned subsidiary, ReceptoPharm, Inc, is developing technologies for the development of drugs for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis ("MS").

  • The minority-owned holding, Infectech, Inc., is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

  • Lastly, the wholly-owned subsidiary Portage BioMed is developing novel and proprietary drug delivery systems to be used with various drug therapies in the treatment of diseases. Their primary research is in creating innovative systems for the safer and more efficient distribution of existing chemotherapeutic agents in the treatment of cancer.

    Key Management:
    Rik J Deitsch, Chairman of the Board; President and Chief Executive Officer
    Stanley J Cherelstein, Director; Principal Accounting Officer
    Stewart Lonky, MD, Director; Science Chairman
    Tanivir Khandaker, MD, Director; Partnerships and Acquisition Chairman
    Michael Doherty, Chairman of the Board

    Last Updated: 11-28-05

     Key Statistics

    Ownership: Public

    Web Site: Nutra Pharma Corp.
    Employees: 10
    Symbol: NPHC

  • Industry

     Company News
    Nutra Pharma Corp. (NPHC) Announces Addition Of Keith Gordon, DVM To The Company's Medical Advisory Board 1/20/2015 10:05:39 AM
    Nutra Pharma Corp. (NPHC) Announces Manufacturing Release Of Pet Pain-Away And Delivery Of Initial Orders 12/18/2014 11:28:59 AM
    Nutra Pharma Corp. (NPHC) Letter To Shareholders 12/8/2014 2:43:56 PM
    Nutra Pharma Corp. (NPHC) Retains BUYINS.NET To Surveil Short Sellers And Market-Makers 8/25/2014 10:40:05 AM
    Nutra Pharma Corp. (NPHC) Provides Nyloxin® Marketing Updates 8/19/2014 11:29:36 AM
    Nutra Pharma Corp. (NPHC) Announces Infrastructure Improvements To Handle Increased Sales 7/24/2014 10:08:08 AM
    Nutra Pharma Corp. (NPHC) Announces Nyloxin Television Commercial Rollout 6/26/2014 11:23:50 AM
    Nutra Pharma Corp. (NPHC) Announces Completion Of Commercials By 6/26/2014 11:19:43 AM
    Nutra Pharma Corp. (NPHC) Announces Contracts For Nyloxin Television Commercials 6/11/2014 8:58:29 AM
    Nutra Pharma Corp. (NPHC) To Seek GSA Certification, Will Market Military Strength Nyloxin To Governmental Agencies And The DoD 4/23/2014 8:43:52 AM